TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

Detection of Circulating Tumor DNA Using a Tissue-Free Epigenomic Assay Is a Highly Prognostic Biomarker in Early-Stage Triple-Negative Breast Cancer.

Foluso O Ademuyiwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.